Pierre Véron

  Merck & Co. is a company governed by the laws of the United States of America and the owner of European patent EP 0 724 444, filed on 11 October 1994, which relates to a “method of treating…

Institut Pasteur is the holder of European patent No. 0 178 978, which relates to “Cloned DNA sequences, hybridizable with genomic RNA of lymphadenopathy-associated virus (LAV)”. Institut Pasteur…

Institut Pasteur, a private foundation recognised of public utility, developed some research which made it possible to identify the HIV-1/VIH retrovirus which is responsible for AIDS, and to define…

  Aventis Pharma is the holder of supplementary protection certificate (SPC) No. 960006 related to European patent EP 253 738 granted on 31 January 1990, concerning the anti-cancer proprietary…

  After a procedure of twenty-odd years, various companies and a natural person were held liable for the infringement of French Patent No. 2 590 192 and European Patent No. 0 229 575 held by…

  The company Laboratoires Medidom (hereinafter referred to as “Medidom”) is the holder of European patent No. 520 414, entitled “Process for the preparation of diacetylrhein”, which concerns “a…

  Unilever NV (hereinafter referred to as “Unilever”) is the holder of a European patent filed in English on 19 March 2001 and the grant of which was published in the European Patent Bulletin dated…

What happens when the same invention is covered by a French national patent and a European patent claiming the priority of the French application and when the European patent lapses after having…

Institut Pasteur is the holder of European patent No. 0 178 978 entitled “Cloned DNA sequences, hybridizable with genomic RNA of “lymphadenopathy-associated virus (LAV)””, granted on 6 February 1991…